PPARgamma agonists as new therapeutic agents for the treatment of Alzheimer's disease

Exp Neurol. 2006 Jun;199(2):245-8. doi: 10.1016/j.expneurol.2006.04.006. Epub 2006 May 30.

Author

Gary Landreth¹

Affiliation

¹ Department of Neurosciences, Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. gel2@case.edu

PMID: 16733054
DOI: 10.1016/j.expneurol.2006.04.006

No abstract available

Publication types

Review
Comment

MeSH terms

Alzheimer Disease / drug therapy*
Animals
Disease Models, Animal
Humans
PPAR gamma / agonists*
PPAR gamma / physiology
Rosiglitazone
Thiazolidinediones / therapeutic use*

Substances

PPAR gamma
Thiazolidinediones
Rosiglitazone